 | • レポートコード：GIR-23F3895 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Plasma-derived Factor VIII Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の血漿由来第VIII因子の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 血漿由来第VIII因子市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・200IU、250IU アプリケーション別セグメントは次のように区分されます。 ・病院、薬局 世界の血漿由来第VIII因子市場の主要なマーケットプレーヤーは以下のとおりです。 ・Takeda、Octapharma、CSL、Grifols、Greencross、Kedrion、BPL、Hualan Bio、RAAS 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 血漿由来第VIII因子の概要 - タイプ別分析（2017年vs2021年vs2028年）：200IU、250IU - アプリケーション別分析（2017年vs2021年vs2028年）：病院、薬局 - 世界の血漿由来第VIII因子市場規模・予測 - 世界の血漿由来第VIII因子生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Takeda、Octapharma、CSL、Grifols、Greencross、Kedrion、BPL、Hualan Bio、RAAS ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：200IU、250IU ・アプリケーション別分析2017年-2028年：病院、薬局 ・血漿由来第VIII因子の北米市場分析 - 血漿由来第VIII因子の北米市場：タイプ別市場規模2017年-2028年 - 血漿由来第VIII因子の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・血漿由来第VIII因子のヨーロッパ市場分析 - ：血漿由来第VIII因子のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：血漿由来第VIII因子のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・血漿由来第VIII因子のアジア太平洋市場分析 - 血漿由来第VIII因子のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 血漿由来第VIII因子のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・血漿由来第VIII因子の南米市場分析 - 血漿由来第VIII因子の南米市場：タイプ別市場規模2017年-2028年 - 血漿由来第VIII因子の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・血漿由来第VIII因子の中東・アフリカ市場分析 - 血漿由来第VIII因子の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 血漿由来第VIII因子の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Plasma-derived Factor VIII market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Plasma-derived Factor VIII market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Plasma-derived Factor VIII global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 200IU segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Plasma-derived Factor VIII include Takeda, Octapharma, CSL, Grifols, and Greencross, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Plasma-derived Factor VIII market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
200IU
250IU
Market segment by Application can be divided into
Hospital
Pharmacy
The key market players for global Plasma-derived Factor VIII market are listed below:
Takeda
Octapharma
CSL
Grifols
Greencross
Kedrion
BPL
Hualan Bio
RAAS
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Plasma-derived Factor VIII product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Plasma-derived Factor VIII, with price, sales, revenue and global market share of Plasma-derived Factor VIII from 2019 to 2022.
Chapter 3, the Plasma-derived Factor VIII competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Plasma-derived Factor VIII breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Plasma-derived Factor VIII market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Plasma-derived Factor VIII.
Chapter 13, 14, and 15, to describe Plasma-derived Factor VIII sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Plasma-derived Factor VIII Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Plasma-derived Factor VIII Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 200IU
1.2.3 250IU
1.3 Market Analysis by Application
1.3.1 Overview: Global Plasma-derived Factor VIII Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Plasma-derived Factor VIII Market Size & Forecast
1.4.1 Global Plasma-derived Factor VIII Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Plasma-derived Factor VIII Sales in Volume (2017-2028)
1.4.3 Global Plasma-derived Factor VIII Price (2017-2028)
1.5 Global Plasma-derived Factor VIII Production Capacity Analysis
1.5.1 Global Plasma-derived Factor VIII Total Production Capacity (2017-2028)
1.5.2 Global Plasma-derived Factor VIII Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Plasma-derived Factor VIII Market Drivers
1.6.2 Plasma-derived Factor VIII Market Restraints
1.6.3 Plasma-derived Factor VIII Trends Analysis
2 Manufacturers Profiles
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Plasma-derived Factor VIII Product and Services
2.1.4 Takeda Plasma-derived Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Octapharma
2.2.1 Octapharma Details
2.2.2 Octapharma Major Business
2.2.3 Octapharma Plasma-derived Factor VIII Product and Services
2.2.4 Octapharma Plasma-derived Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 CSL
2.3.1 CSL Details
2.3.2 CSL Major Business
2.3.3 CSL Plasma-derived Factor VIII Product and Services
2.3.4 CSL Plasma-derived Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Grifols
2.4.1 Grifols Details
2.4.2 Grifols Major Business
2.4.3 Grifols Plasma-derived Factor VIII Product and Services
2.4.4 Grifols Plasma-derived Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Greencross
2.5.1 Greencross Details
2.5.2 Greencross Major Business
2.5.3 Greencross Plasma-derived Factor VIII Product and Services
2.5.4 Greencross Plasma-derived Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Kedrion
2.6.1 Kedrion Details
2.6.2 Kedrion Major Business
2.6.3 Kedrion Plasma-derived Factor VIII Product and Services
2.6.4 Kedrion Plasma-derived Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 BPL
2.7.1 BPL Details
2.7.2 BPL Major Business
2.7.3 BPL Plasma-derived Factor VIII Product and Services
2.7.4 BPL Plasma-derived Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Hualan Bio
2.8.1 Hualan Bio Details
2.8.2 Hualan Bio Major Business
2.8.3 Hualan Bio Plasma-derived Factor VIII Product and Services
2.8.4 Hualan Bio Plasma-derived Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 RAAS
2.9.1 RAAS Details
2.9.2 RAAS Major Business
2.9.3 RAAS Plasma-derived Factor VIII Product and Services
2.9.4 RAAS Plasma-derived Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Plasma-derived Factor VIII Breakdown Data by Manufacturer
3.1 Global Plasma-derived Factor VIII Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Plasma-derived Factor VIII Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Plasma-derived Factor VIII
3.4 Market Concentration Rate
3.4.1 Top 3 Plasma-derived Factor VIII Manufacturer Market Share in 2021
3.4.2 Top 6 Plasma-derived Factor VIII Manufacturer Market Share in 2021
3.5 Global Plasma-derived Factor VIII Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Plasma-derived Factor VIII Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Plasma-derived Factor VIII Market Size by Region
4.1.1 Global Plasma-derived Factor VIII Sales in Volume by Region (2017-2028)
4.1.2 Global Plasma-derived Factor VIII Revenue by Region (2017-2028)
4.2 North America Plasma-derived Factor VIII Revenue (2017-2028)
4.3 Europe Plasma-derived Factor VIII Revenue (2017-2028)
4.4 Asia-Pacific Plasma-derived Factor VIII Revenue (2017-2028)
4.5 South America Plasma-derived Factor VIII Revenue (2017-2028)
4.6 Middle East and Africa Plasma-derived Factor VIII Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Plasma-derived Factor VIII Sales in Volume by Type (2017-2028)
5.2 Global Plasma-derived Factor VIII Revenue by Type (2017-2028)
5.3 Global Plasma-derived Factor VIII Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Plasma-derived Factor VIII Sales in Volume by Application (2017-2028)
6.2 Global Plasma-derived Factor VIII Revenue by Application (2017-2028)
6.3 Global Plasma-derived Factor VIII Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Plasma-derived Factor VIII Sales by Type (2017-2028)
7.2 North America Plasma-derived Factor VIII Sales by Application (2017-2028)
7.3 North America Plasma-derived Factor VIII Market Size by Country
7.3.1 North America Plasma-derived Factor VIII Sales in Volume by Country (2017-2028)
7.3.2 North America Plasma-derived Factor VIII Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Plasma-derived Factor VIII Sales by Type (2017-2028)
8.2 Europe Plasma-derived Factor VIII Sales by Application (2017-2028)
8.3 Europe Plasma-derived Factor VIII Market Size by Country
8.3.1 Europe Plasma-derived Factor VIII Sales in Volume by Country (2017-2028)
8.3.2 Europe Plasma-derived Factor VIII Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Plasma-derived Factor VIII Sales by Type (2017-2028)
9.2 Asia-Pacific Plasma-derived Factor VIII Sales by Application (2017-2028)
9.3 Asia-Pacific Plasma-derived Factor VIII Market Size by Region
9.3.1 Asia-Pacific Plasma-derived Factor VIII Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Plasma-derived Factor VIII Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Plasma-derived Factor VIII Sales by Type (2017-2028)
10.2 South America Plasma-derived Factor VIII Sales by Application (2017-2028)
10.3 South America Plasma-derived Factor VIII Market Size by Country
10.3.1 South America Plasma-derived Factor VIII Sales in Volume by Country (2017-2028)
10.3.2 South America Plasma-derived Factor VIII Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Plasma-derived Factor VIII Sales by Type (2017-2028)
11.2 Middle East & Africa Plasma-derived Factor VIII Sales by Application (2017-2028)
11.3 Middle East & Africa Plasma-derived Factor VIII Market Size by Country
11.3.1 Middle East & Africa Plasma-derived Factor VIII Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Plasma-derived Factor VIII Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Plasma-derived Factor VIII and Key Manufacturers
12.2 Manufacturing Costs Percentage of Plasma-derived Factor VIII
12.3 Plasma-derived Factor VIII Production Process
12.4 Plasma-derived Factor VIII Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Plasma-derived Factor VIII Typical Distributors
13.3 Plasma-derived Factor VIII Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Plasma-derived Factor VIII Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Plasma-derived Factor VIII Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Takeda Basic Information, Manufacturing Base and Competitors
Table 4. Takeda Major Business
Table 5. Takeda Plasma-derived Factor VIII Product and Services
Table 6. Takeda Plasma-derived Factor VIII Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Octapharma Basic Information, Manufacturing Base and Competitors
Table 8. Octapharma Major Business
Table 9. Octapharma Plasma-derived Factor VIII Product and Services
Table 10. Octapharma Plasma-derived Factor VIII Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. CSL Basic Information, Manufacturing Base and Competitors
Table 12. CSL Major Business
Table 13. CSL Plasma-derived Factor VIII Product and Services
Table 14. CSL Plasma-derived Factor VIII Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Grifols Basic Information, Manufacturing Base and Competitors
Table 16. Grifols Major Business
Table 17. Grifols Plasma-derived Factor VIII Product and Services
Table 18. Grifols Plasma-derived Factor VIII Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Greencross Basic Information, Manufacturing Base and Competitors
Table 20. Greencross Major Business
Table 21. Greencross Plasma-derived Factor VIII Product and Services
Table 22. Greencross Plasma-derived Factor VIII Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Kedrion Basic Information, Manufacturing Base and Competitors
Table 24. Kedrion Major Business
Table 25. Kedrion Plasma-derived Factor VIII Product and Services
Table 26. Kedrion Plasma-derived Factor VIII Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. BPL Basic Information, Manufacturing Base and Competitors
Table 28. BPL Major Business
Table 29. BPL Plasma-derived Factor VIII Product and Services
Table 30. BPL Plasma-derived Factor VIII Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 32. Hualan Bio Major Business
Table 33. Hualan Bio Plasma-derived Factor VIII Product and Services
Table 34. Hualan Bio Plasma-derived Factor VIII Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. RAAS Basic Information, Manufacturing Base and Competitors
Table 36. RAAS Major Business
Table 37. RAAS Plasma-derived Factor VIII Product and Services
Table 38. RAAS Plasma-derived Factor VIII Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Plasma-derived Factor VIII Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Plasma-derived Factor VIII Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Plasma-derived Factor VIII, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Plasma-derived Factor VIII Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Plasma-derived Factor VIII Production Site of Key Manufacturer
Table 44. Plasma-derived Factor VIII New Entrant and Capacity Expansion Plans
Table 45. Plasma-derived Factor VIII Mergers & Acquisitions in the Past Five Years
Table 46. Global Plasma-derived Factor VIII Sales by Region (2017-2022) & (K Units)
Table 47. Global Plasma-derived Factor VIII Sales by Region (2023-2028) & (K Units)
Table 48. Global Plasma-derived Factor VIII Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Plasma-derived Factor VIII Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Plasma-derived Factor VIII Sales by Type (2017-2022) & (K Units)
Table 51. Global Plasma-derived Factor VIII Sales by Type (2023-2028) & (K Units)
Table 52. Global Plasma-derived Factor VIII Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Plasma-derived Factor VIII Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Plasma-derived Factor VIII Price by Type (2017-2022) & (USD/Unit)
Table 55. Global Plasma-derived Factor VIII Price by Type (2023-2028) & (USD/Unit)
Table 56. Global Plasma-derived Factor VIII Sales by Application (2017-2022) & (K Units)
Table 57. Global Plasma-derived Factor VIII Sales by Application (2023-2028) & (K Units)
Table 58. Global Plasma-derived Factor VIII Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Plasma-derived Factor VIII Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Plasma-derived Factor VIII Price by Application (2017-2022) & (USD/Unit)
Table 61. Global Plasma-derived Factor VIII Price by Application (2023-2028) & (USD/Unit)
Table 62. North America Plasma-derived Factor VIII Sales by Country (2017-2022) & (K Units)
Table 63. North America Plasma-derived Factor VIII Sales by Country (2023-2028) & (K Units)
Table 64. North America Plasma-derived Factor VIII Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Plasma-derived Factor VIII Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Plasma-derived Factor VIII Sales by Type (2017-2022) & (K Units)
Table 67. North America Plasma-derived Factor VIII Sales by Type (2023-2028) & (K Units)
Table 68. North America Plasma-derived Factor VIII Sales by Application (2017-2022) & (K Units)
Table 69. North America Plasma-derived Factor VIII Sales by Application (2023-2028) & (K Units)
Table 70. Europe Plasma-derived Factor VIII Sales by Country (2017-2022) & (K Units)
Table 71. Europe Plasma-derived Factor VIII Sales by Country (2023-2028) & (K Units)
Table 72. Europe Plasma-derived Factor VIII Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Plasma-derived Factor VIII Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Plasma-derived Factor VIII Sales by Type (2017-2022) & (K Units)
Table 75. Europe Plasma-derived Factor VIII Sales by Type (2023-2028) & (K Units)
Table 76. Europe Plasma-derived Factor VIII Sales by Application (2017-2022) & (K Units)
Table 77. Europe Plasma-derived Factor VIII Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Plasma-derived Factor VIII Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Plasma-derived Factor VIII Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Plasma-derived Factor VIII Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Plasma-derived Factor VIII Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Plasma-derived Factor VIII Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Plasma-derived Factor VIII Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Plasma-derived Factor VIII Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Plasma-derived Factor VIII Sales by Application (2023-2028) & (K Units)
Table 86. South America Plasma-derived Factor VIII Sales by Country (2017-2022) & (K Units)
Table 87. South America Plasma-derived Factor VIII Sales by Country (2023-2028) & (K Units)
Table 88. South America Plasma-derived Factor VIII Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Plasma-derived Factor VIII Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Plasma-derived Factor VIII Sales by Type (2017-2022) & (K Units)
Table 91. South America Plasma-derived Factor VIII Sales by Type (2023-2028) & (K Units)
Table 92. South America Plasma-derived Factor VIII Sales by Application (2017-2022) & (K Units)
Table 93. South America Plasma-derived Factor VIII Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Plasma-derived Factor VIII Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Plasma-derived Factor VIII Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Plasma-derived Factor VIII Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Plasma-derived Factor VIII Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Plasma-derived Factor VIII Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Plasma-derived Factor VIII Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Plasma-derived Factor VIII Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Plasma-derived Factor VIII Sales by Application (2023-2028) & (K Units)
Table 102. Plasma-derived Factor VIII Raw Material
Table 103. Key Manufacturers of Plasma-derived Factor VIII Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Plasma-derived Factor VIII Typical Distributors
Table 107. Plasma-derived Factor VIII Typical Customers
List of Figures
Figure 1. Plasma-derived Factor VIII Picture
Figure 2. Global Plasma-derived Factor VIII Revenue Market Share by Type in 2021
Figure 3. 200IU
Figure 4. 250IU
Figure 5. Global Plasma-derived Factor VIII Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Pharmacy
Figure 8. Global Plasma-derived Factor VIII Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Plasma-derived Factor VIII Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Plasma-derived Factor VIII Sales (2017-2028) & (K Units)
Figure 11. Global Plasma-derived Factor VIII Price (2017-2028) & (USD/Unit)
Figure 12. Global Plasma-derived Factor VIII Production Capacity (2017-2028) & (K Units)
Figure 13. Global Plasma-derived Factor VIII Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Plasma-derived Factor VIII Market Drivers
Figure 15. Plasma-derived Factor VIII Market Restraints
Figure 16. Plasma-derived Factor VIII Market Trends
Figure 17. Global Plasma-derived Factor VIII Sales Market Share by Manufacturer in 2021
Figure 18. Global Plasma-derived Factor VIII Revenue Market Share by Manufacturer in 2021
Figure 19. Plasma-derived Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Plasma-derived Factor VIII Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Plasma-derived Factor VIII Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Plasma-derived Factor VIII Sales Market Share by Region (2017-2028)
Figure 23. Global Plasma-derived Factor VIII Revenue Market Share by Region (2017-2028)
Figure 24. North America Plasma-derived Factor VIII Revenue (2017-2028) & (USD Million)
Figure 25. Europe Plasma-derived Factor VIII Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Plasma-derived Factor VIII Revenue (2017-2028) & (USD Million)
Figure 27. South America Plasma-derived Factor VIII Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Plasma-derived Factor VIII Revenue (2017-2028) & (USD Million)
Figure 29. Global Plasma-derived Factor VIII Sales Market Share by Type (2017-2028)
Figure 30. Global Plasma-derived Factor VIII Revenue Market Share by Type (2017-2028)
Figure 31. Global Plasma-derived Factor VIII Price by Type (2017-2028) & (USD/Unit)
Figure 32. Global Plasma-derived Factor VIII Sales Market Share by Application (2017-2028)
Figure 33. Global Plasma-derived Factor VIII Revenue Market Share by Application (2017-2028)
Figure 34. Global Plasma-derived Factor VIII Price by Application (2017-2028) & (USD/Unit)
Figure 35. North America Plasma-derived Factor VIII Sales Market Share by Type (2017-2028)
Figure 36. North America Plasma-derived Factor VIII Sales Market Share by Application (2017-2028)
Figure 37. North America Plasma-derived Factor VIII Sales Market Share by Country (2017-2028)
Figure 38. North America Plasma-derived Factor VIII Revenue Market Share by Country (2017-2028)
Figure 39. United States Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Plasma-derived Factor VIII Sales Market Share by Type (2017-2028)
Figure 43. Europe Plasma-derived Factor VIII Sales Market Share by Application (2017-2028)
Figure 44. Europe Plasma-derived Factor VIII Sales Market Share by Country (2017-2028)
Figure 45. Europe Plasma-derived Factor VIII Revenue Market Share by Country (2017-2028)
Figure 46. Germany Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Plasma-derived Factor VIII Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Plasma-derived Factor VIII Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Plasma-derived Factor VIII Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Plasma-derived Factor VIII Revenue Market Share by Region (2017-2028)
Figure 55. China Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Plasma-derived Factor VIII Sales Market Share by Type (2017-2028)
Figure 62. South America Plasma-derived Factor VIII Sales Market Share by Application (2017-2028)
Figure 63. South America Plasma-derived Factor VIII Sales Market Share by Country (2017-2028)
Figure 64. South America Plasma-derived Factor VIII Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Plasma-derived Factor VIII Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Plasma-derived Factor VIII Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Plasma-derived Factor VIII Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Plasma-derived Factor VIII Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Plasma-derived Factor VIII in 2021
Figure 76. Manufacturing Process Analysis of Plasma-derived Factor VIII
Figure 77. Plasma-derived Factor VIII Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source